RHA 2, RHA 3, RHA 4 dermal fillers

Implant, Dermal, For Aesthetic Use

FDA Premarket Approval P170002 S004

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Implementation of the international council for harmonization (ich) elemental impurities guideline and change in the test method and specification to assay aluminum by the raw material supplier for the hyaluronic acid

DeviceRHA 2, RHA 3, RHA 4 dermal fillers
Classification NameImplant, Dermal, For Aesthetic Use
Generic NameImplant, Dermal, For Aesthetic Use
ApplicantTEOXANE S.A.
Date Received2019-03-12
Decision Date2019-11-01
PMAP170002
SupplementS004
Product CodeLMH
Advisory CommitteeGeneral & Plastic Surgery
Supplement Type135 Review Track For 30-day Notice
Supplement ReasonProcess Change - Manufacturer/sterilizer/packager/supplier
Expedited ReviewNo
Combination Product Yes
Applicant Address TEOXANE S.A. rue De Lyon 105 geneva 1203

Supplemental Filings

Supplement NumberDateSupplement Type
P170002Original Filing
S025 2022-12-27 30-day Notice
S024
S023
S022
S021 2022-03-17 Real-time Process
S020 2022-01-31 30-day Notice
S019 2021-07-26 Real-time Process
S018 2021-07-16 30-day Notice
S017 2021-04-26 30-day Notice
S016 2021-04-02 30-day Notice
S015 2021-03-29 30-day Notice
S014 2021-03-16 Special (immediate Track)
S013 2021-02-17 30-day Notice
S012
S011
S010 2020-07-20 135 Review Track For 30-day Notice
S009 2020-02-14 30-day Notice
S008 2020-02-13 30-day Notice
S007 2019-11-13 30-day Notice
S006
S005 2019-06-18 Real-time Process
S004 2019-03-12 135 Review Track For 30-day Notice
S003 2019-03-12 30-day Notice
S002 2019-02-21 30-day Notice
S001

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.